SOPHiA GENETICS SA
SOPH
$3.12
-$0.18-5.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.73M | 15.85M | 15.81M | 15.78M | 17.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.73M | 15.85M | 15.81M | 15.78M | 17.05M |
| Cost of Revenue | 5.63M | 5.20M | 5.03M | 5.37M | 5.15M |
| Gross Profit | 12.10M | 10.65M | 10.78M | 10.41M | 11.90M |
| SG&A Expenses | 20.52M | 18.19M | 17.84M | 19.78M | 21.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -116.00K | -43.00K | -18.00K | -6.00K | -177.00K |
| Total Operating Expenses | 35.18M | 31.22M | 30.81M | 34.54M | 35.97M |
| Operating Income | -17.44M | -15.36M | -15.01M | -18.76M | -18.92M |
| Income Before Tax | -14.54M | -18.31M | -15.03M | -13.39M | -24.05M |
| Income Tax Expenses | 616.00K | 130.00K | 161.00K | 316.00K | 8.00K |
| Earnings from Continuing Operations | -15.16M | -18.44M | -15.19M | -13.70M | -24.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.16M | -18.44M | -15.19M | -13.70M | -24.06M |
| EBIT | -17.44M | -15.36M | -15.01M | -18.76M | -18.92M |
| EBITDA | -16.96M | -14.09M | -13.76M | -17.42M | -18.45M |
| EPS Basic | -0.23 | -0.28 | -0.23 | -0.21 | -0.37 |
| Normalized Basic EPS | -0.14 | -0.17 | -0.14 | -0.13 | -0.23 |
| EPS Diluted | -0.23 | -0.28 | -0.23 | -0.21 | -0.37 |
| Normalized Diluted EPS | -0.14 | -0.17 | -0.14 | -0.13 | -0.23 |
| Average Basic Shares Outstanding | 65.90M | 66.38M | 65.92M | 65.31M | 65.03M |
| Average Diluted Shares Outstanding | 65.90M | 66.38M | 65.92M | 65.31M | 65.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
